TodayToday / Industry / StoryAnthropic’s Drug Discovery Dreams: ‘It Is Not A Side Effort’ShareWed 11 Nov · 2:00 PM, updated 2:00 PMFirst seen Wed 11 Nov · 2:00 PMUpdated 2:00 PMLimited coverage, taperingAnthropic · IndustryANT$88.91▼9.7%Reported by Forbes1 source ↓Anthropic’s recent purchase of one-man firm Mithril is just the tip of the spear in how it hopes to use AI to accelerate drug development as it seeks a $1.4 trillion valuation in the public markets.SourcesForbes2:00 PMRead ↗Anthropic’s Drug Discovery Dreams: ‘It Is Not A Side Effort’Stocks in this storyDayWeekMonthYearChange since open: 20 Nov to 21 Nov 2026ANTAnthropic, stories$88.91Down8.5%After hours$87.79Down1.3%Last refresh 00:00More on AnthropicAnthropic sets IPO price range at $70 to $78 per shareTue 10 Nov · 36 outletsAnthropic seeks valuation of up to $1.4 trillion in IPOMon 26 Oct · 25 outlets